Recent advances on CDK inhibitors: An insight by means of in silico methods

Risultato della ricerca: Articlepeer review

30 Citazioni (Scopus)


The cyclin dependent kinases (CDKs) are a small family of serine/threonine protein kinases that can act as a potential therapeutic target in several proliferative diseases, including cancer. This short review is a survey on the more recent research progresses in the field achieved by using in silico methods. All the "armamentarium" available to the medicinal chemists (docking protocols and molecular dynamics, fragment-based, de novo design, virtual screening, and QSAR) has been employed to the discovery of new, potent, and selective inhibitors of cyclin dependent kinases. The results cited herein can be useful to understand the nature of the inhibitor-target interactions, and furnish an insight on the structural/molecular requirements necessary to achieve the required selectivity against cyclin dependent kinases over other types of kinases.
Lingua originaleEnglish
pagine (da-a)300-315
Numero di pagine16
RivistaEuropean Journal of Medicinal Chemistry
Stato di pubblicazionePublished - 2017

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.3000.3004???
  • ???subjectarea.asjc.3000.3002???
  • ???subjectarea.asjc.1600.1605???


Entra nei temi di ricerca di 'Recent advances on CDK inhibitors: An insight by means of in silico methods'. Insieme formano una fingerprint unica.

Cita questo